Tumor antigens recognized by cytolytic T lymphocytes: Present perspectives for specific immunotherapy

This publication has 30 references indexed in Scilit:

• A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
  The Journal of Experimental Medicine, 1992
• Galactose Oxidation in the Design of Immunogenic Vaccines
  Science, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
  Science, 1991
• The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
  The Journal of Experimental Medicine, 1991
• Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
  The Journal of Experimental Medicine, 1990
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
  Cell, 1990
• Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells
  Cell, 1989
• The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
  Cell, 1986
• Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens.
  The Journal of Experimental Medicine, 1980